Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Making sense of big data in health research: towards an EU action plan

  • 1, 2Email author,
  • 3Email author,
  • 4,
  • 5,
  • 6,
  • 7,
  • 8,
  • 9,
  • 10, 11, 12,
  • 13, 14,
  • 15,
  • 16,
  • 17,
  • 18,
  • 19,
  • 20,
  • 21,
  • 22,
  • 23,
  • 24,
  • 25,
  • 26,
  • 27,
  • 28,
  • 29,
  • 30,
  • 31,
  • 32, 33,
  • 20,
  • 34,
  • 35,
  • 36,
  • 37,
  • 38,
  • 12,
  • 39,
  • 40,
  • 41,
  • 42,
  • 43,
  • 44,
  • 45,
  • 46,
  • 41,
  • 47,
  • 3,
  • 48,
  • 49,
  • 50,
  • 36,
  • 50,
  • 51,
  • 52,
  • 53,
  • 20,
  • 54 and
  • 55, 56
Genome Medicine20168:118

https://doi.org/10.1186/s13073-016-0376-y

Received: 26 October 2016

Accepted: 26 October 2016

Published: 7 November 2016

The original article was published in Genome Medicine 2016 8:71

Erratum

The published article [1] has two points of confusion in the section entitled “Technical challenges related to the management of electronic health records”. Firstly, the International Rare Diseases Research Consortium (IRDiRC) has developed policies and guidelines on approaches to data sharing meant to enable and improve the development of diagnoses and therapies for rare diseases. However, at present, IRDiRC has not developed best practices for the management of electronic health records (EHRs). Secondly, RARE-Bestpractices is a European Commission 7th Framework Programme (FP7) funded initiative, independent of IRDiRC. RARE-Bestpractices contributes to IRDiRC goals and objectives; however the initiative itself is not sponsored nor connected to IRDiRC.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
European Institute for Systems Biology and Medicine, Paris, France
(2)
CIRI-UMR5308, CNRS-ENS-INSERM-UCBL, Université de Lyon, Lyon, France
(3)
Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
(4)
Wellcome Trust Sanger Institute, Cambridge, UK
(5)
Health Services Management Training Centre, Faculty of Health and Public Services, Semmelweis University, Budapest, Hungary
(6)
Centre for Personalised Medicine, Linköping University, Linköping, Sweden
(7)
Translational & Bioinformatics, Pfizer Inc., Cambridge, USA
(8)
Institute for Health Sciences, Zaragoza, Spain
(9)
ELIXIR, Cambridge, UK
(10)
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
(11)
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
(12)
Max Planck Institute for Informatics, Saarbrücken, Germany
(13)
Príncipe Felipe Research Center, Valencia, Spain
(14)
University of Florida, Institute of Food and Agricultural Sciences (IFAS), Gainesville, USA
(15)
Bluecompanion Ltd, London, UK
(16)
Technology, Data & Analytics, KPMG Luxembourg, Société Coopérative, Luxembourg, Luxembourg
(17)
Department of Human Genetics, Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands
(18)
Information Technology Department, European Organization for Nuclear Research (CERN), Geneva 23, Switzerland
(19)
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
(20)
European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK
(21)
Department of Pediatric Oncology/Hematology, Saarland University, Homburg, Germany
(22)
Project Management Jülich, Forschungszentrum Jülich GmbH, Jülich, Germany
(23)
Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands
(24)
Data Science Institute, Imperial College London, London, UK
(25)
CNAG-CRG, Center for Genomic Regulation, Barcelona Institute for Science and Technology (BIST), Barcelona, Spain
(26)
Institute of Software Technology and Interactive Systems, TU Wien, Vienna, Austria
(27)
The Association of the British Pharmaceutical Industry, London, UK
(28)
Department of Medical Statistics, RWTH-Aachen University, Universitätsklinikum Aachen, Aachen, Germany
(29)
SYNAPSE Research Management Partners, Barcelona, Spain
(30)
Department of Infection, Immunity and Cardiovascular Disease and Insigneo Institute for In-Silico Medicine, Medical School, University of Sheffield, Sheffield, UK
(31)
Department of Statistics, School of Mathematics, University of Leeds, Leeds, UK
(32)
Department of Medical & Molecular Genetics, London, UK
(33)
Genomics England, London, UK
(34)
National and Kapodistrian University of Athens, Medical School, Athens, Greece
(35)
Vitromics Healthcare Holding B.V., ’s-Hertogenbosch, The Netherlands
(36)
Fraunhofer Institute for Molecular Biology and Applied Ecology ScreeningPort, Hamburg, Germany
(37)
ITTM S.A., Esch-sur-Alzette, Luxembourg
(38)
Research Business Technology, Cambridge, UK
(39)
Health Economics & Outcomes Research, Diegem, Belgium
(40)
Janssen Pharmaceutica N.V., R&D G3O, Beerse, Belgium
(41)
Faculty of Life Sciences, University of Manchester, Manchester, UK
(42)
UMR3664 IC/CNRS, Institut Curie, Section Recherche, Pavillon Pasteur, Paris cedex 05, France
(43)
Linguamatics Ltd, Cambridge, UK
(44)
PwC Luxembourg, Luxembourg, Luxembourg
(45)
Philips, Eindhoven, The Netherlands
(46)
Department of Public Health and Primary Care, KU Leuven Kulak, Kortrijk, Belgium
(47)
INCLIVA Health Research Institute, University of Valencia, CIBERobn ISCIII, Valencia, Spain
(48)
Swiss Institute of Bioinformatics (SIB) and University of Basel, Basel, Switzerland
(49)
Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain
(50)
EuroBioForum Foundation, Vlaardingen, The Netherlands
(51)
Integrated BioBank of Luxembourg, Luxembourg, Luxembourg
(52)
Technopolis Group, Brighton, UK
(53)
Hospital Clinic of Barcelona, Institute d’Investigacions Biomediques August Pi Sunyer (IDIBAPS), Barcelona, Spain
(54)
European Platform for Patients’ Organisations, Science and Industry (Epposi), Brussels, Belgium
(55)
CRS4, Ed.1 POLARIS, Pula, Italy
(56)
BBMRI-ERIC, Graz, Austria

Reference

  1. Auffray C, Balling R, Barroso I, Bencze L, Benson M, Bergeron J, et al. Making sense of big data in health research: Towards an EU action plan. Genome Med. 2016;8:71.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement